Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.

Autor:in

Ogg, Monica; Jonsson, Colleen B; Camp, Jeremy V; Hooper, Jay W;

Schlagwörter

Animals; Antiviral Agents/administration & dosage*; Antiviral Agents/adverse effects; Cricetinae; Disease Models, Animal; Female; Hantavirus/drug effects*; Hantavirus/physiology; Hantavirus Pulmonary Syndrome/drug therapy; Hantavirus Pulmonary Syndrome/prevention & control*; Hantavirus Pulmonary Syndrome/virology; Humans; Mesocricetus; Nasal Cavity/virology; Ribavirin/administration & dosage*; Ribavirin/adverse effects;

CC Lizenz

CCBY

ISSN/eISSN

1999-4915 -

WoS ID

WOS:000330523200006